Planned Rule 144 sale of 87 LH shares

A holder of Laboratory Corporation of America Holdings (LH) common stock has filed a Rule 144 notice to sell 87 shares through Fidelity Brokerage Services on the NYSE, with an approximate sale date of 02/12/2026 and an aggregate market value of $25,266.54.

Rhea-AI Filing Summary

A holder of Laboratory Corporation of America Holdings (LH) common stock has filed a Rule 144 notice to sell 87 shares through Fidelity Brokerage Services on the NYSE, with an approximate sale date of 02/12/2026 and an aggregate market value of $25,266.54.

The 87 shares were acquired on 02/11/2026 via restricted stock vesting from the issuer as compensation. In the past three months, Jonathan Meltzer sold LH common stock in two transactions: 88 shares on 02/09/2026 for $24,246.64 and 91 shares on 02/10/2026 for $25,187.89.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the latest Rule 144 notice for LH disclose?

The notice discloses a planned sale of 87 shares of LH common stock on or about 02/12/2026. The shares are to be sold on the NYSE through Fidelity Brokerage Services for an aggregate market value of $25,266.54.

How were the 87 LH shares in the Rule 144 filing acquired?

The 87 LH shares were acquired on 02/11/2026 through restricted stock vesting from the issuer. The filing states the nature of the payment as compensation, indicating these shares represent an equity award that recently vested before the planned sale.

What recent LH stock sales are reported for Jonathan Meltzer?

The filing reports two recent LH common stock sales by Jonathan Meltzer. He sold 88 shares on 02/09/2026 for gross proceeds of $24,246.64 and 91 shares on 02/10/2026 for gross proceeds of $25,187.89, both listed as separate transactions.

On which exchange will the 87 LH shares be sold under Rule 144?

The 87 LH common shares covered by the Rule 144 notice are planned to be sold on the New York Stock Exchange. The transaction will be executed through Fidelity Brokerage Services, which is listed as the broker handling the sale.

What class of LH securities is covered by this Rule 144 filing?

The filing covers LH common stock as the class of securities to be sold. It specifies that 87 common shares are intended for sale, with an aggregate market value of $25,266.54, and identifies the NYSE as the securities exchange.

How many LH shares are outstanding according to the Rule 144 notice?

The notice reports that 82,900,000 LH common shares are outstanding. This figure provides context for the 87-share planned sale, indicating the relative size of the transaction compared with the total shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 09:49 AM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002103998
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	LABCORP HOLDINGS INC.
SEC File Number	001-11353
Address of Issuer	358 S MAIN ST BURLINGTON NORTH CAROLINA 27215
Phone	3362291127
Name of Person for Whose Account the Securities are To Be Sold	Meltzer Jonathan C
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	87	25266.54	82900000	02/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/11/2026	Restricted Stock Vesting	Issuer			87	02/11/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jonathan Meltzer 358 South Main Street Burlington NC 27215	Common	02/09/2026	88	24246.64
Jonathan Meltzer 358 South Main Street Burlington NC 27215	Common	02/10/2026	91	25187.89

144: Remarks and Signature

Remarks
Date of Notice	02/12/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Jonathan Meltzer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)